Followers | 240 |
Posts | 12051 |
Boards Moderated | 0 |
Alias Born | 04/05/2009 |
Monday, July 24, 2017 7:16:09 PM
Guernsey, 19 July 2017 - Eurocastle Investment Limited ("Eurocastle" or the "Company") today announces that doBank has reported that the Joint Global Coordinators of the recently completed IPO have exercised their greenshoe option in full. Accordingly, Eurocastle and other Fortress affiliates have each sold down an additional 1.735 million shares at the IPO price of €9.00 per share. Settlement of the shares will take place on 21 July 2017.
In aggregate, the IPO has resulted in the sale of 38.17 million shares in doBank, of which Eurocastle has sold 19.085 million shares. The Company, together with other Fortress Affiliates, retains a joint 51.22% interest in doBank (excluding 1,750,000 of treasury shares).
The doBank securities may not be offered or sold in the United States unless they are registered under the United States Securities Act of 1933 or exempt from registration. The securities are not and are not intended to be registered in the United States.
ABOUT EUROCASTLE
Eurocastle Investment Limited is a publicly traded closed-ended investment company that focuses on investing in performing and non-performing loans and other real estate related assets primarily in Italy. The Company is Euro denominated and is listed on Euronext Amsterdam under the symbol "ECT". Eurocastle is managed by an affiliate of Fortress Investment Group LLC, a leading global investment manager. For more information regarding Eurocastle Investment Limited and to be added to our email distribution list, please visit www.eurocastleinv.com.
http://www.nasdaq.com/press-release/eurocastle-investment-limited--eurocastle-announces-exercise-of-the-greenshoe-option-in-dobank-ipo-20170719-00070
"Someone said it takes 30 years to be an instant success" - Gabriel Barbier-Mueller, CEO of Harwood International
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM